Barinthus Biotherapeutics plc (FRA:2AB)
Germany
· Delayed Price · Currency is EUR 0.6050
-0.0100 (-1.63%)
Last updated: Dec 4, 2025, 8:05 AM CET
Barinthus Biotherapeutics Revenue
In the year 2024, Barinthus Biotherapeutics had annual revenue of $14.97M USD with 1,766.46% growth.
Revenue
$14.97M
Revenue Growth
+1,766.46%
P/S Ratio
n/a
Revenue / Employee
$142.56K
Employees
105
Market Cap
25.32M EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |